Business
Notice of Results and Investor Presentation
Vulcan Two Group plc will release its Full Year Results on Thursday, May 21, 2026, and will host a live investor presentation at 12:30pm BST via the Investor Meet Company platform. The management team will discuss the company's vision, buy-and-build strategy, and the growth opportunities in the UK ePharmacy market. The company is focused on becoming the UK's leading regulated ePharmacy platform, having recently acquired CloudRx, Webmed, and Hyperdrug, establishing a diversified and profitable business with recurring revenues and strong cash generation. Disclaimer*
About this update from Vulcan Two Group Plc
[{"type":"text","content":"\n\n \n18 May 2026\nVulcan Two Group plc\n(the \"Company\", \"Group\" or \"Vulcan Two\")\n \nNotice of Results and Investor Presentation\n \nFollowing the release of the Company's Full Year Results on Thursday 21 May 2026, the management team of Vulcan Two Group plc, the company aiming to create the UK's leading regulated ePharmacy through buy-and-build, will be hosting a live presentation at 12:30pm (BST) via the Investor Meet Company platform.\n \nMichael Kraftman (CEO), Keith Butcher (CFO) and Brendan O'Brien (COO) will present an overview of the Company's vision, its proven buy-and-build strategy, and the significant growth opportunity within the UK ePharmacy market.\n \nThe presentation is open to all existing and potential shareholders and registration can be completed via the following link: www.investormeetcompany.com/vulcan-two-group-plc/register-investor \n \nQuestions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.\n \nFor further information please contact:\n \n\n\n\n\nVulcan Two Group plc\nMichael Kraftman, Chief Executive Officer\nKeith Butcher, Chief Finance Officer\nBrendan O'Brien, Chief Operating Officer\nwww.vulcantwo.com\n\n\nEmail: [email protected]\n\n\n\n\nCanaccord Genuity Limited\n(Nominated Adviser and Sole Broker)\nSimon Bridges / Harry Pardoe / Elizabeth Halley-Stott\n\n\nTel: +44 (0) 20 7523 8000\n\n\n\n\n\nAlma Strategic Communications\n(Financial PR)\nJustine James / Sam Modlin / Will Merison\n\n\nEmail: [email protected]\nTel: +44 (0) 20 3405 0205\n\n\n\n\n \nNotes to Editors\nVulcan Two Group plc (AIM:VUL) is creating the UK's leading regulated ePharmacy platform, through its disciplined buy-and-build strategy. Following the acquisitions of CloudRx, Webmed and Hyperdrug in March 2026, the Group has established a diversified, profitable platform spanning B2B prescription fulfilment and B2C digital pharmacy services, with a high proportion of recurring revenues and strong cash generation. Future growth is expected to be supported through the acquisition of complementary businesses, expansion into new sectors or markets, and investment in long-term assets.\nThe Group is led by an experienced management team with deep healthcare,...